MENU
+Compare
CTKB
Stock ticker: NASDAQ
AS OF
Aug 11, 04:59 PM (EDT)
Price
$3.81
Change
-$0.22 (-5.46%)
Capitalization
512.71M

CTKB Cytek Biosciences Forecast, Technical & Fundamental Analysis

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches... Show more

CTKB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CTKB with price predictions
Aug 08, 2025

Momentum Indicator for CTKB turns positive, indicating new upward trend

CTKB saw its Momentum Indicator move above the 0 level on July 25, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 56 similar instances where the indicator turned positive. In of the 56 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CTKB just turned positive on July 25, 2025. Looking at past instances where CTKB's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

CTKB moved above its 50-day moving average on July 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTKB advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 102 cases where CTKB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CTKB moved out of overbought territory on August 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTKB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CTKB broke above its upper Bollinger Band on July 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTKB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.358) is normal, around the industry mean (57.379). P/E Ratio (0.000) is within average values for comparable stocks, (37.765). CTKB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.644). CTKB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (2.648) is also within normal values, averaging (90.474).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTKB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
CTKB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CTKB is expected to report earnings to fall 85.25% to 0 cents per share on November 11

Cytek Biosciences CTKB Stock Earnings Reports
Q3'25
Est.
$-0.01
Q2'25
Est.
$-0.04
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.01
Q3'24
Est.
$0.01
The last earnings report on August 06 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 702.74K shares outstanding, the current market capitalization sits at 512.71M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
47215 Lakeview Boulevard
Phone
+1 877 922-9835
Employees
676
Web
https://www.cytekbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LHCTX18.560.15
+0.81%
Lord Abbett Health Care R5
ITHVX57.510.38
+0.67%
Hartford Capital Appreciation R6
SCCVX13.090.06
+0.46%
AB Small Cap Value C
EMGRX10.340.02
+0.19%
Nuveen Small Cap Select A
ICEIX24.56-0.04
-0.16%
Macquarie International Core Eq I

CTKB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CTKB has been loosely correlated with GMED. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CTKB jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
-1.95%
GMED - CTKB
46%
Loosely correlated
+8.47%
CRL - CTKB
46%
Loosely correlated
-0.69%
TMCI - CTKB
45%
Loosely correlated
+7.92%
VREX - CTKB
43%
Loosely correlated
+21.38%
ENOV - CTKB
43%
Loosely correlated
-0.28%
More

Groups containing CTKB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
-1.95%
Medical/Nursing Services
industry (227 stocks)
31%
Poorly correlated
+0.31%
Health Services
industry (442 stocks)
31%
Poorly correlated
+0.88%